切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - NUAK2 - Farnesoid X receptors (FXRs) - HCV Proteases

10 件产品

每页
清除全部
  1. WZ4003
    B1374 WZ4003
    Target: NUAK1|NUAK2
    Summary: NUAK1/2抑制剂
      ≥7.85 mg/mL
      insoluble in H2O
  2. Obeticholic Acid
    B4888 Obeticholic Acid
     2 Citation
    中文名: 奥贝胆酸
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥21.5 mg/mL
      insoluble in H2O
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. XL335
    B1528 XL335
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥20.4 mg/mL
      insoluble in H2O
  6. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  7. Daclatasvir (BMS-790052)
    A5618 Daclatasvir (BMS-790052)
    中文名: 达卡他韦
    Target: HCV Proteases
    Summary: HCV NS5A抑制剂
      ≥36.6 mg/mL
      insoluble in H2O
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. Simeprevir
    A3820 Simeprevir
     1 Citation
    中文名: 西咪匹韦
    Target: HCV Proteases
    Summary: HCV NS3/4A蛋白酶抑制剂
      ≥18.75 mg/mL
      insoluble in H2O
  10. Danoprevir (RG7227)
    A4024 Danoprevir (RG7227)
    中文名: 丹诺瑞韦
    Target: HCV Proteases
    Summary: HCV NS3/4A蛋白酶抑制剂
      ≥32.6 mg/mL
      insoluble in H2O

10 件产品

每页